Know Cancer

or
forgot password

Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.


N/A
18 Years
N/A
Open (Enrolling)
Female
Gynecologic Cancer, Breast Cancer, Thoracic Cancer, Gastrointestinal Cancer

Thank you

Trial Information

Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.


Inclusion Criteria:



1. Women who have a diagnosis of metastatic breast, gynecologic, thoracic, or
gastrointestinal malignancy. Women diagnosed with non-solid organ tumors (i.e.,
lymphoma, leukemia) will be excluded as their symptom profile in advanced/metastatic
disease is dissimilar.

2. Reason for admission must be for symptom management from cancer or cancer therapy.

3. Patients must be age 18 or older.

4. Only patients cared for at the Robert H. Lurie Comprehensive Cancer Center (RHLCCC)
will be eligible for this small pilot study.

5. Patients must not be enrolled in hospice care.

6. Patients must have a performance status 0-3 (ECOG scale).

7. Patients must be alert and oriented to time, place, and person. Must be able to
answer questions.

8. Patients must be able to speak, read, and communicate in English.

9. Patients must have a signed consent and authorization for research and be amenable to
be followed for outcomes/response throughout and after hospitalization.

Exclusion Criteria:

-

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Identify perceived symptom burden and quality of life in our female patients with advanced gynecologic, breast, thoracic, or gastrointestinal malignancies.

Outcome Description:

We will compare the symptom scores of the control and the intervention groups to determine if the overall symptom burden scores are lower and patient satisfaction scores are higher in the group who receive targeted intervention combined with education.

Outcome Time Frame:

3 years

Safety Issue:

No

Principal Investigator

Emily Berry, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Northwestern University

Authority:

United States: Institutional Review Board

Study ID:

STU00064629

NCT ID:

NCT01833637

Start Date:

October 2012

Completion Date:

October 2015

Related Keywords:

  • Gynecologic Cancer
  • Breast Cancer
  • Thoracic Cancer
  • Gastrointestinal Cancer
  • Advanced Care Planning
  • Palliative Care
  • Women
  • Breast Neoplasms
  • Thoracic Neoplasms
  • Gastrointestinal Neoplasms

Name

Location

Northwestern Memorial HospitalChicago, Illinois  60611